BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.89 CNY | +1.95% |
|
-7.01% | -25.79% |
| May. 06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Evolution of the average Target Price on Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
7251ee4815aed9eba47.cpc5X9hbsR-gWkqp14jnq25hW8Nox9iFc-BG7ag6Jnc.Stt7a54S8inZMSX2s8qh5gFVKIRehb3HQJcustlceRMI_QE7oQ6AW-IXLQ~f5c32474dc2801305febf0d5f35c3e33
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.233
CNY
Average target price
14.21
CNY
Spread / Average Target
+72.66%
High Price Target
15.02
CNY
Spread / Highest target
+82.39%
Low Price Target
13.41
CNY
Spread / Lowest Target
+62.92%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2315 Stock
- Consensus Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
